EUVIMEDEUVIMED entdecken
Fallbericht

Case report: Severe consequence of unnecessary retention of a TIVAD, phlegmasia cerulea dolens—A case for better stewardship

Louis Delorme iD, Cédric Foussier iD, Geoffroy Aubouin iD, Olivier Brenet iD, Jane Muret iD

The Journal of Vascular Access · 04.11.2026

DOI: 10.1177/11297298261497779 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Vascular Access, online erschienen am 04.11.2026. Verfasst von Louis Delorme und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Critical Care and Pain Management, Institut Curie, Paris, France. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Totally implanted venous access devices (TIVADs) have been used for decades in cancer management. Traditionally placed in the chest wall, they can also be inserted in the upper arm using peripherally inserted central catheter methodologies (PICC-Ports), which are recognized as a safe and comfortable alternative. However, as with all vascular access devices, their safety profile depends on appropriate management, including timely removal. We report a case of Phlegmasia Cerulea Dolens (PCD)—critical venous ischemia—occurring a year after treatment completion due to a retained device. A 59-year-old breast cancer patient presented with arm edema ipsilateral to a PICC-Port, 1 year after chemotherapy had ended. Despite an initial “normal” duplex ultrasound (DUS), her condition worsened into full-blown PCD with cyanosis and loss of pulses. CT angiography revealed massive thrombosis, and standard anticoagulation failed, necessitating interventional radiology for subclavian stenting. While TIVADs are established as a safe method of chemotherapy administration, their safety remains contingent upon adherence to insertion protocols, timely removal, and knowledge of international guidelines. Leaving an inactive device for 12 months post-treatment represents a significant risk. Furthermore, a false-negative initial ultrasound led to a critical diagnostic delay, underscoring that strong clinical suspicion should sometimes override early negative imaging to prevent progression from deep vein thrombosis to PCD. Ultimately, “lost to follow-up” patients with retained TIVADs and non-compliance with international guidelines represent a major iatrogenic risk in cancer management.

Schlagwörter

Stichwörter der Autor:innen

PICC-portoncologyphlegmasia cerulea dolensvascular accessvenous thrombosis

Autor:innen und Institutionen

  • Department of Anesthesiology, Critical Care and Pain Management, Institut Curie, Paris, France.
  • Vascular Access Unit, Institut Curie, Paris, France.
  • Department of Radiology, Institut Médico-chirurgical Montsouris, Paris, France.

ORCID-Profile: Louis Delorme, Cédric Foussier, Geoffroy Aubouin, Olivier Brenet, Jane Muret

Zitieren

APA

Delorme, L., Foussier, C., Aubouin, G., Brenet, O., & Muret, J. (2026). Case report: Severe consequence of unnecessary retention of a TIVAD, phlegmasia cerulea dolens—A case for better stewardship. The Journal of Vascular Access. https://doi.org/10.1177/11297298261497779

Vancouver

Delorme L, Foussier C, Aubouin G, Brenet O, Muret J. Case report: Severe consequence of unnecessary retention of a TIVAD, phlegmasia cerulea dolens—A case for better stewardship. The Journal of Vascular Access. 2026. doi:10.1177/11297298261497779

BibTeX
@article{Delorme2026,
  author = {Delorme, Louis and Foussier, Cédric and Aubouin, Geoffroy and Brenet, Olivier and Muret, Jane},
  title = {Case report: Severe consequence of unnecessary retention of a TIVAD, phlegmasia cerulea dolens—A case for better stewardship},
  journal = {The Journal of Vascular Access},
  year = {2026},
  doi = {10.1177/11297298261497779}
}
Kostenlos starten →